医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Highlands Recovery and Institute of Behavioural Medicine Opens Near Sydney

2024年06月12日 AM07:01
このエントリーをはてなブックマークに追加


 

SYDNEY

Highlands Recovery, a world-class institute of behavioural medicine and rehabilitation, has opened its doors. Located halfway between Sydney and Canberra, the luxury facility is now accepting residents who are dealing with trauma, addiction, and mental health disorders.

Led by CEO Cameron Francis and Clinical Director Resh Joseph MBBS, MSc, Highlands offers a residential program, exclusive accommodations, and comprehensive aftercare.

“Our mission is to be a world-class centre of excellence for the treatment of trauma and trauma-related disorders,” says Francis, who has set up an international advisory body to ensure access to the latest research and methodologies for trauma-related recovery.

Residents will experience individualised dialectical behaviour therapy (DBT) with Joseph and his team. DBT has shown promising results in helping patients with suicidal ideation, self-harming behaviour, and addiction.

Joseph shared his recovery philosophy, explaining, “When you see past the behaviour, addiction is the sigh of an oppressed creature. Flowers of false consolation growing on a chain that binds us to our pain, our trauma, and our shame. True recovery seeks to break the chain, that we may live free from the need for false consolation.”

Residents receive clinical treatment six days a week, featuring personal yoga sessions, equine therapy, physical training, and somatic massage therapy to heal the mind, body, and soul for long-lasting recovery.

The residential program requires a minimum stay of 28 days, with options for semi-private or private accommodations. Limited availability ensures privacy and anonymity among residents. Highlands’ Aftercare Program extends for 12–24 months post-recovery, providing continued support as clients transition back into their daily lives.

About the Leadership Team

Cameron Francis is an organisational psychologist and the founder of Future Leaders International, which builds leadership development programs across AsiaPac.

Resh Joseph is a psychotherapist with decades of experience treating addiction and trauma-related disorders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240611363861/en/

CONTACT

Grigorij Richters

XWECAN

Grig@xwecan.com

同じカテゴリーの記事 

  • Kirin Holdings开始要约收购FANCL以使其成为全资子公司
  • Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
  • Kirin Holdings Commences Tender Offer To Make FANCL A Wholly-Owned Subsidiary
  • Data of InnoCare’s Robust Pipelines Presented at the European Hematology Association (EHA) 2024 Hybrid Congress
  • セルトリオン、EULAR 2024にて、関節リウマチ(RA)患者向けACTEMRA/RoActemra(トシリズマブ)のバイオシミラー候補であるCT-P47の第III相試験の有望な結果を示す